Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
Saved in:
Main Authors: | Richard P. Phipps, <?layout cmd="newline"?> Patricia J. Sime, Steven H. Bernstein, Tatiana M. Garcia-Bates, Geniece M. Lehmann, Patricia J. Simpson-Haidaris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/834612 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differentiation Potential of Pancreatic Fibroblastoid Cells/Stellate Cells: Effects of Peroxisome Proliferator-Activated Receptor Gamma Ligands
by: M.-L. Kruse, et al.
Published: (2011-01-01) -
Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
by: Jean Dallongeville, et al.
Published: (2009-01-01) -
Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
by: Chen Zhang, et al.
Published: (2020-01-01) -
Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01) -
Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
by: Jihan Youssef, et al.
Published: (2002-01-01)